Carol K. Redmond | Academic Influence

Carol K. Redmond's AcademicInfluence.com Rankings

Carol K. Redmond

Mathematics

#6613

World Rank

#9127

Historical Rank

Statistics

#706

World Rank

#793

Historical Rank

mathematics Degrees

Download Badge

Mathematics

Carol K. Redmond's Degrees

Masters Statistics Stanford University
Bachelors Mathematics University of California, Berkeley

Similar Degrees You Can Earn

Best Online Bachelor's in Math 2025

Why Is Carol K. Redmond Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Carol K. Redmond is an American biostatistician known for her research on breast cancer. She is Distinguished Service Professor Emerita in the Department of Biostatistics at the University of Pittsburgh.

(See a Problem?)

Carol K. Redmond's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials (2005) (6940)
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. (1999) (5389)
Tamoxifen for early breast cancer: an overview of the randomised trials (1998) (3764)
Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. (1985) (2054)
Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. (1989) (1558)
A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. (1989) (1427)
Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. (1985) (1318)
Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. (1995) (1131)
Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update (1983) (1010)
Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. (1988) (1003)
Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. (1996) (884)
Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. (1994) (877)
Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. (1993) (821)
Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. (1997) (756)
Validation studies for models projecting the risk of invasive and total breast cancer incidence. (1999) (704)
1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings. (1975) (704)
Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. (1994) (662)
The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. (1993) (656)
Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. (1990) (623)
Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowe (1990) (593)
Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. (1994) (562)
Significance of ipsilateral breast tumour recurrence after lumpectomy (1991) (517)
The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. (1981) (431)
Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06. (1988) (430)
Endocrine treatment of breast cancer in women. (1990) (410)
Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01. (1988) (399)
Comparison of radical mastectomy with alternative treatments for primary breast cancer: A first report of results from a prospective randomized clinical trial (1977) (391)
A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. (1989) (379)
Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16. (1990) (302)
Treatment of primary breast cancer with chemotherapy and tamoxifen. (1981) (296)
Pathologic findings from the national surgical adjuvant breast project (NSABP) protocol B‐17. Intraductal carcinoma (ductal carcinoma in situ) (1995) (291)
Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients. (1990) (283)
Pathologic findings from the national surgical adjuvant breast project protocol B‐06 10‐year pathologic and clinical prognostic discriminants (1993) (279)
Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer. (1983) (274)
Detection and significance of occult axillary node metastases in patients with invasive breast cancer (1978) (249)
Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: pathological findings from NSABP protocol B-06. (1992) (242)
The contribution of recent nsabp clinical trials of primary breast cancer therapy to an understanding of tumor biology—an overview of findings (1980) (236)
Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and (1996) (226)
Determinants of black/white differences in colon cancer survival. (1995) (219)
Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial. (1986) (209)
Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial. (1995) (208)
Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience. (1985) (205)
Pathologic findings from the national surgical adjuvant breast project (protocol no. 4). V. significance of axillary nodal micro‐ and macrometastases (1978) (204)
Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02. (1990) (204)
Histological characteristics of breast carcinoma in blacks and whites. (1994) (198)
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials (2019) (197)
Breast cancer: factors associated with stage at diagnosis in black and white women. Black/White Cancer Survival Study Group. (1993) (196)
L‐phenylalanine mustard (L‐PAM) in the management of primary breast cancer: An update of earlier findings and a comparison with those utilizing L‐PAM plus 5‐fluorouracil (5‐FU) (1977) (190)
Histologic grading of breast cancer. (1980) (185)
Pathologic findings from the national surgical adjuvant breast project (protocol no. 4). I. Observations concerning the multicentricity of mammary cancer (1975) (173)
Correlation of estrogen receptor and pathologic characteristics of invasive breast cancer (1980) (170)
Findings from NSABP protocol no. b‐04: Comparison of radical mastectomy with alternative treatments. II. The clinical and biologic significance of medial‐central breast cancers (1981) (161)
Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. (1986) (155)
Conservative management of intraductal carcinoma (DCIS) of the breast (1991) (152)
Doxorubicin-containing regimens for the treatment of stage II breast cancer: The National Surgical Adjuvant Breast and Bowel Project experience. (1989) (151)
Breast cancer adjuvant therapy: time to consider its time-dependent effects. (2011) (150)
Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4). VI. Invasive papillary cancer. (1980) (150)
CANCER EXPERIENCE AMONG COKE BY‐PRODUCT WORKERS (1976) (136)
Occupationally Related Cancer Risk Among Coke Oven Workers: 30 Years of Follow-Up (1995) (131)
Eight-year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast Cancer (1989) (128)
Pathologic findings from the national surgical adjuvant breast project (protocol 4): Discriminants for 15‐year survival (1993) (127)
Lumpectomy for breast cancer: an update of the NSABP experience. National Surgical Adjuvant Breast and Bowel Project. (1992) (121)
Long-term mortality study of steelworkers. (1976) (121)
Maximum‐Likelihood Estimation of the Parameters of the Gompertz Survival Function (1970) (121)
1‐Phenylalanine mustard (L‐PAM) in the management of premenopausal patients with primary breast cancer. Lack of association of disease‐free survival with depression of ovarian function (1979) (119)
Prolonging tamoxifen therapy for primary breast cancer. Findings from the National Surgical Adjuvant Breast and Bowel Project clinical trial. (1987) (117)
Findings from NSABP protocol no. B‐04‐comparison of radical mastectomy with alternative treatments for primary breast cancer. I. Radiation compliance and its relation to treatment outcome (1980) (115)
Long-term tamoxifen citrate use and potential ocular toxicity. (1998) (114)
Cardiovascular Diseases in the United States (1972) (110)
New perspective on cancer of the contralateral breast: a marker for assessing tamoxifen as a preventive agent. (1991) (109)
Breast tumor recurrence following lumpectomy with and without breast irradiation: an overview of recent NSABP findings. (1992) (108)
Pathologic findings from the national surgical adjuvant breast project (protocol no. 4) vi. discriminants for five‐year treatment failure (1980) (106)
Reported methodological quality of split-mouth studies. (2007) (106)
Tubulolobular invasive breast cancer: a variant of lobular invasive cancer. (1977) (103)
DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S‐Phase fraction to outcome of patients in NSABP B‐04 (1991) (100)
Pathologic findings from the national surgical adjuvant breast project. (Protocol no. 4). III. The significance of extranodal extension of axillary metastases. (1976) (96)
Pathologic findings from the national surgical adjuvant breast and bowel projects (NSABP) prognostic discriminants for 8‐year survival for node‐negative invasive breast cancer patients (1990) (95)
Long-term mortality study of steelworkers. VI. Mortality from malignant neoplasms among coke oven workers. (1972) (94)
Relationship between cholecystectomy and ascending colon cancer (1980) (87)
Prognosis among African‐American women and white women with lymph node negative breast carcinoma (1997) (77)
The methodologic dilemma in retrospectively correlating the amount of chemotherapy received in adjuvant therapy protocols with disease-free survival. (1983) (72)
An Epidemiological Study of Exposure to Coal Tar Pitch Volatiles Among Coke Oven Workers (1975) (72)
Serum level changes after administration of a pharmacologic dose of beta-carotene. (1988) (71)
Systemic therapy in node-negative patients: updated findings from NSABP clinical trials. National Surgical Adjuvant Breast and Bowel Project. (1992) (71)
Tumor size and regional lymph node metastasis in colorectal cancer a preliminary analysis from the NSABP clinical trials (1983) (66)
A perspective concerning the relation of duration of symptoms to treatment failure in patients with breast cancer (1977) (64)
Pathological findings from the national surgical adjuvant breast project (Protocol No. 4). IV. Significance of tumor necrosis. (1978) (63)
Cancer mortality among coke oven workers. (1983) (62)
Pathologic findings from the national surgical adjuvant breast project (protocol no. 4). II. The significance of regional node histology other than sinus histiocytosis in invasive mammary cancer. (1976) (61)
Correlation of primary breast cancer histopathology and estrogen receptor content (1981) (53)
Systemic adjuvant therapy in treatment of primary operable breast cancer: National Surgical Adjuvant Breast and Bowel Project experience. (1986) (52)
Long-term mortality study of steelworkers. IV. Mortality by work area. (1970) (50)
Pathologic findings from the national surgical adjuvant breast project. VIII. Relationship of chemotherapeutic responsiveness to tumor differentiation (1983) (47)
Systemic therapy in patients with node-negative breast cancer. A commentary based on two National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials. (1989) (45)
Disease‐free survival at intervals during and following completion of adjuvant chemotherapy: The NSABP experience from three breast cancer protocols (1981) (42)
Breast cancer estrogen and progesterone receptor values: their distribution, degree of concordance, and relation to number of positive axillary nodes. (1983) (42)
Using alternative comparison populations to assess occupation-related mortality risk. Results for the high nickel alloys workers cohort. (1998) (39)
Chromosomal aberrations and sister-chromatid exchanges in lymphocytes from coke oven workers. (1988) (38)
Biostatistics in Clinical Trials (2002) (37)
Recent developments in the use of systemic adjuvant therapy for the treatment of breast cancer. (1992) (36)
Prognostic factors in NSABP studies of women with node-negative breast cancer. National Surgical Adjuvant Breast and Bowel Project. (1992) (36)
Fraud in breast-cancer trials. (1994) (33)
Adjuvant Therapy for Node-Negative Breast Cancer (1989) (33)
Tumor nuclear grade, estrogen receptor, and progesterone receptor: Their value alone or in combination as indicators of outcome following adjuvant therapy for breast cancer (2005) (32)
The relationship between the geographic distribution of lung cancer incidence and cigarette smoking in Allegheny County, Pennsylvania. (1982) (32)
Evolution of knowledge related to breast cancer heterogeneity: a 25-year retrospective. (2008) (31)
Trauma associated with cardiac dysrhythmias: results from a large matched case-control study. (2006) (30)
Acute toxicity during adjuvant chemotherapy for breast cancer: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience from 1717 patients receiving single and multiple agents. (1981) (29)
Multistage modeling of lung cancer mortality among arsenic-exposed copper-smelter workers. (1989) (29)
Evaluation of the worth of Corynebacterium parvum in conjunction with chemotherapy as adjuvant treatment for primary breast cancer: Eight‐year results from the national surgical adjuvant breast and bowel project B‐10 (1990) (27)
Comparison of methods for assessing occupational hazards. (1975) (25)
A multistage approach to the cohort analysis of lifetime lung cancer risk among steelworkers exposed to coke oven emissions. (1988) (23)
Long-term mortality experience of steelworkers. VIII. Mortality patterns of open hearth steelworkers (a preliminary report). (1975) (20)
Relation of estrogen and/or progesterone receptor content of breast cancer to patient outcome following adjuvant chemotherapy (2005) (19)
Estrogen receptor, a marker for human breast cancer differentiation and patient prognosis. (1981) (15)
KARYOTYPIC PROFILES OF WOMEN AFTER CLOMIPHENE CITRATE THERAPY (1973) (15)
Contribution of organic particulates to respiratory cancer. (1986) (13)
Site-specific cancer mortality among workers involved in the production of high nickel alloys. (1984) (13)
Limitations and advantages of meta-analysis in clinical trials. (1988) (12)
Issues and findings in the evaluation of occupational risk among women high nickel alloys workers. (1999) (11)
The use of retirees to evaluate occupational hazards. (1976) (11)
Long-term mortality study of stellworkers. VII. Mortality patterns among crane operators. (1974) (11)
Long-term mortality study of steelworkers. IX. Mortality patterns among sheet and tin mill workers. (1975) (11)
Heart disease mortality among black migrants: a study of Ohio residents (1960-1967). (1975) (10)
Recent developments in the multistage modeling of cohort data for carcinogenic risk assessment. (1991) (10)
Mortality of steelworkers employed in hot jobs. (1979) (10)
Evaluation of multiple causes of death in occupational mortality studies. (1978) (10)
FACTORS RELATED TO PROGRESSION OF CERVICAL ATYPIAS (1971) (9)
Impact of randomized clinical trials on therapy of primary breast cancer: the NSABP overview. (1982) (9)
Clinical trials and the surgical treatment of breast cancer. (1978) (7)
Adjuvant chemotherapy for breast cancer: an overview of NSABP findings. (1982) (7)
Parallel‐Line Assay (2005) (7)
Sensitive population subsets in relation to effects of low doses. (1981) (6)
Screening for geographic heterogeneity of disease rates: application to cancer incidence in Allegheny County, Pennsylvania, 1969-71. (1985) (6)
Factors related to progression of cervical atypias. (1971) (6)
Challenges in Monitoring the Breast Cancer Prevention Trial (2006) (6)
Surgery for early breast cancer. (1996) (5)
A reliability study of a neonatal seizure scoring system (1994) (5)
Models for estimating worksite WBGT. (1978) (4)
Design, analysis and interpretation of long-term mortality studies of coke oven workers : Epidemiological studies of industrial pollutants (1993) (4)
The use of retirees to evaluate occupational hazards. II. Comparison of cause specific mortality by work area. (1978) (4)
Design and current status of the NSABP breast cancer prevention trial. (1996) (4)
Analysis of clinical, epidemiologic, and laboratory data on chronic fatigue syndrome. (1991) (4)
Epidemiologic and pedigree study of the occurrence of lymphosarcoma from 1953 to 1971 in a closed herd of Jersey cows. (1974) (4)
A brief overview of findings from NSABP trials of adjuvant therapy. (1984) (3)
Chemotherapy and tamoxifen for breast cancer. (1981) (3)
Selection, follow-up, and analysis in the Coke Oven Study. (1985) (3)
A comparison of two and three years of adjuvant tamoxifen. (1989) (3)
Slope–Ratio Assay (2005) (2)
Factors related to the incidence of stomach cancer in the Pittsburgh Standard Metropolitan Statistical Area. (1977) (2)
Long-term mortality study of steelworkers. 3. Follow-up. (1969) (1)
Slope–Ratio Assay† (2014) (1)
Computations of adjusted rates and lifetime risks from occupational cohort data: a program package using FORTRAN and GLIM. (1991) (1)
Leukemia in Breast Cancer Patients Following Adjuvant Chemotherapy or Postoperative Radiation (2016) (1)
Statistical approaches for relating end results to amount of drug received in breast cancer therapy trials (1981) (0)
Data monitoring at the national surgical adjuvant project for breast and bowel cancers (NSABP) (1980) (0)
Design, Implementation, and Interpretation of Clinical Trials (2010) (0)
Prolonging Tamoxifen Therapy for Primary Breast Cancer (2020) (0)
Trends in cancer incidence in Allegheny County, Pennsylvania, 1937-71. (1977) (0)
Reply to J.J. Dignam (2011) (0)
Statistical concepts and biomedical research. (1996) (0)
93 Issues in the design of a multicenter trial comparing radiation therapy to expandable esophageal stents for patients with advanced unresectable esophageal cancer (1997) (0)
Vincristine is Associated with the Risk of Azoospermia in Adult Male Survivors of Childhood Malignancies (1992) (0)
Randomization with stratification and institution balance for multiinstitution clinical trials (1982) (0)
Parallel-Line Assay† (2014) (0)
An overview of the breast protocols of NSAPB. (1982) (0)
107 Global monitoring of prevention trials: the breast cancer prevention trial (bcpt) experience (1997) (0)
University of Pittsburgh Departments of Biostatistics and Statistics (2012) (0)
Sample size considerations in chronic disease clinical trials: Number of patients versus follow-up time (1981) (0)
Treatment of stage I breast cancer: the NSABP experience. (1989) (0)
Demographic characteristics and quality of life factors among the participants of the breast cancer prevention trial (1998) (0)
104 Design of the economic evaluation of the sortie trial (1997) (0)
Review: Cardiovascular Diseases in the United States by Iwao Moriyama, Dean E. Krueger, and Jeremiah Stamler (1972) (0)

This paper list is powered by the following services:

Other Resources About Carol K. Redmond

en.wikipedia.org

What Schools Are Affiliated With Carol K. Redmond?

Carol K. Redmond is affiliated with the following schools: